Pharmacokinetics of a novel oral slow-release form of misoprostol

Human Reproduction

Volumn 20, Issue 12, 2005, Pages 3414-3418

  Fiala, Christian ^a,c   Aronsson, A ^a   Granath, F ^a   Stephansson, O ^a   Seyberth, H W ^b   Watzer, B ^b   Gemzell Danielsson, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Gynmed Ambulatorium   (Austria)

Author keywords

Induced abortion; Misoprostol; Oral; Pharmacokinetics; Slow release

Indexed keywords

CODEINE; MISOPROSTOL; PARACETAMOL;

ABDOMINAL PAIN; ABORTION; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; NAUSEA AND VOMITING; NORMAL HUMAN; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; TANDEM MASS SPECTROMETRY;

EID: 28544442828     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei229     Document Type: Article

References (18)

1. Aronsson A, Bygdeman M and Gernzell-Danielsson K (2004a) Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 19,81-84.
2. Aronsson A, Helstrom L and Gernzell-Danielsson K (2004b) Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: A randomized comparison. Contraception 69,165-169.
3. Bygdeman M, Christensen NJ, Dimov V and Green K (1984) Termination of pregnancy by a slow release device containing 16, 16-dimethyl-trans-delta 2 PGE1 methyl ester. Asia Oceania J Obstet Gynaecol 10,359-365.
4. Cameron IT and Baird DT (1986) A controlled release form of 16,16-dimethyl-trans-delta 2-PGE, methyl ester for early abortion. Contraception 33,121-125.
5. Chen D, Tsay R-J, Lin H-I, Chen H, Chao SC and Ku H (2000) Stabilization and sustained-release effect of Misoprostol with Metharylate copolymer. Int J Pharm 203,141-148.
6. El-Refaey H, Rajasekar D, Abdalla M, Calder L and Templeton A (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. New Engl J Med 332,983-987.
7. Fiala C, Aronsson A, Stephansson O and Gernzell-Danielsson K (2005) Effects of slow release misoprostol on uterine contractility in early pregnancy. Hum Reprod Advance Access published May 26, 2005, 10.1093/ humrep/dei102.
8. Gemzell-Danielsson K, Marions L, Rodriguez A, Spur BW, Wong PY and Bygdeman M (1999) Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93,275-280.
9. Hamoda H, Ashok PW, Flett GM and Templeton A (2004) A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion. Am J Obstet Gynecol 190,55-59.
10. Ho PC, Ngai SW, Liu KL, Wong GC and Lee SW (1997) Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 90,735-738.
11. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6,65-70.
12. SAS Institute Inc (1997) SAS/STAT™ Software: SAS Institute Inc, Cary, NC.
13. Tang OS, Schweer H, Seyberth HW, Lee SW and Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17,332-336.
14. Tang OS, Mok KH and Ho PC (2004) A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod 19,1101-1114. Epub April 7, 2004.
15. von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gernzell-Danielsson K et al, WHO Research Group on Post-Ovulatory Methods for Fertility Regulation (2003) WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Br J Obstet Gynaecol 110,808-818.
16. Watzer B, Seyberth HW and Schweer H (2002) Determination of misoprostol free acid in human breast milk and serum by gas chromatography/negative ion chemical ionization tandem mass spectrometry. J Mass Spectrom 37, 927-933.
17. Weeks AD, Fiala C and Safar P (2005) Misoprostol and the debate over off-label drug use. Br J Obstet Gynaecol 112,269-272.
18. Zieman M, Fong SK, Benowitz NL, Banskter D and Darney PD (1997) Absorption kinetics of misoprostol with oral or vagina administration. Obstet Gynecol 90,88-92.